Screening guidelines for colorectal cancer: What should we advocate to our patients?

Amy Wang, David Lieberman

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Colorectal cancer is the second leading cause of cancer death in the United States. Several medical societies have provided formal guidelines recommending various modalities for average-risk populations. These recommendations universally support the use of high-sensitivity fecal occult blood tests, flexible sigmoidoscopy, and colonoscopy for screening. However, there are differences in the support for fecal DNA stool testing and CT colonography. Regardless of the test, it is imperative that physicians and their patients be aware of the characteristics, benefits, and limitations of each modality. This review discusses the recommendations and provides an up-to-date review of the literature for colorectal cancer screening.

Original languageEnglish (US)
Pages (from-to)8-15
Number of pages8
JournalCurrent Colorectal Cancer Reports
Issue number1
StatePublished - Jan 2010


  • CT colonography
  • Colonoscopy
  • Colorectal cancer
  • Fecal ocult blood tests
  • Screening tests

ASJC Scopus subject areas

  • Hepatology
  • Oncology
  • Gastroenterology


Dive into the research topics of 'Screening guidelines for colorectal cancer: What should we advocate to our patients?'. Together they form a unique fingerprint.

Cite this